Skip to Content
Merck
  • Altered Neuronal Support and Inflammatory Response in Bipolar Disorder Patient-Derived Astrocytes.

Altered Neuronal Support and Inflammatory Response in Bipolar Disorder Patient-Derived Astrocytes.

Stem cell reports (2021-03-06)
Krishna C Vadodaria, Ana P D Mendes, Arianna Mei, Vipula Racha, Galina Erikson, Maxim N Shokhirev, Ruth Oefner, Kelly J Heard, Michael J McCarthy, Lisa Eyler, John R Kelsoe, Renata Santos, Maria C Marchetto, Fred H Gage
ABSTRACT

Bipolar disorder (BD) is characterized by cyclical mood shifts. Studies indicate that BD patients have a peripheral pro-inflammatory state and alterations in glial populations in the brain. We utilized an in vitro model to study inflammation-related phenotypes of astrocytes derived from induced pluripotent stem cells (iPSCs) generated from BD patients and healthy controls. BD astrocytes showed changes in transcriptome and induced a reduction in neuronal activity when co-cultured with neurons. IL-1β-stimulated BD astrocytes displayed a unique inflammatory gene expression signature and increased secretion of IL-6. Conditioned medium from stimulated BD astrocytes reduced neuronal activity, and this effect was partially blocked by IL-6 inactivating antibody. Our results suggest that BD astrocytes are functionally less supportive of neuronal excitability and this effect is partially mediated by IL-6. We confirmed higher IL-6 in blood in a distinct cohort of BD patients, highlighting the potential role of astrocyte-mediated inflammatory signaling in BD neuropathology.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-A2B5 Antibody, clone A2B5-105, clone A2B5-105, Chemicon®, from mouse
Sigma-Aldrich
Anti-Aldh1L1 Antibody, clone N103/39, clone N103/39, from mouse
Sigma-Aldrich
Anti-Nestin Antibody, clone 10C2, clone 10C2, Chemicon®, from mouse